Collaboration Details

Print  Close


Title of Collaborative Activity:

Endocrinologic and Metabolic Drugs Advisory Committee

Description of Collaborative Activity:

This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the Food and Drug Administration (FDA) for drug approval.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

2003

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA